Advertisement

Epidemiology of Sexually Transmitted Infections

  • Aron Gewirtzman
  • Laura Bobrick
  • Kelly Conner
  • Stephen K. Tyring
Chapter

Abstract

Sexually transmitted infections (STIs) are commonplace worldwide and may be caused by bacteria, fungi, protozoa, parasites, or viruses. Epidemiology involves the study of incidence and prevalence of disease in large populations as well as detection of the source and cause of epidemics of infectious disease. Acute diseases tend to have high incidence and low prevalence; chronic diseases may have high prevalence even if incidence is low.

Keywords

Sexual Contact Pelvic Inflammatory Disease Male Circumcision Genital Ulcer Molluscum Contagiosum 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1.  1.
    Global Strategy for the Prevention and Control of Sexually Transmitted Infections: 2006-2015: Breaking the chain of transmission. WHO Press, Geneva (2007)Google Scholar
  2. 2.
    Global Prevalence and Incidence of Curable STIs: World Health Organization (WHO/CDS/CDR/EDC/2001.10), Geneva (2001)Google Scholar
  3. 3.
    WHO/UNAIDS: Sexually transmitted diseases: policies and principles for prevention and care [cited]. www.who.int/hiv/pub/sti/en/prev_care_en.pdf
  4. 4.
    Mayaud, P., Mabey, D.: Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges. Sex. Transm. Infect. 80(3), 174–182 (June 2004)PubMedGoogle Scholar
  5. 5.
    Da Ros, C.T., Schmitt Cda, S.: Global epidemiology of sexually transmitted diseases. Asian J. Androl. 10(1), 110–114 (Jan 2008)PubMedGoogle Scholar
  6. 6.
    Johnston, V.J., Mabey, D.C.: Global epidemiology and control of Trichomonas vaginalis. Curr. Opin. Infect. Dis. 21(1), 56–64 (2008 Feb)PubMedGoogle Scholar
  7. 7.
    Cotch, M.F., Pastorek 2nd, J.G., Nugent, R.P., Hillier, S.L., Gibbs, R.S., Martin, D.H., et al.: Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex. Transm. Dis. 24(6), 353–360 (1997 Jul)PubMedGoogle Scholar
  8. 8.
    Sorvillo, F., Smith, L., Kerndt, P., Ash, L.: Trichomonas vaginalis, HIV, and African-Americans. Emerg. Infect. Dis. 7(6), 927–932 (Nov–Dec 2001)PubMedGoogle Scholar
  9. 9.
    Van der Pol, B.: Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention. Clin. Infect. Dis. 44(1), 23–25 (2007 Jan 1)PubMedGoogle Scholar
  10. 10.
    Krieger, J.N., Alderete, J.F.: Trichomonas vaginalis and trichomoniasis. In: Holmes, K.K., Sparling, P.F., Mardh, P., Lemon, S.M., Stamm, W.E., Plot, P., et al. (eds.) Sexually Transmitted Diseases, 3rd edn, pp. 587–604. McGraw-Hill, New York (1999)Google Scholar
  11. 11.
    Bowden, F.J., Paterson, B.A., Mein, J., Savage, J., Fairley, C.K., Garland, S.M., et al.: Estimating the prevalence of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and human papillomavirus infection in indigenous women in northern Australia. Sex. Transm. Infect. 75(6), 431–434 (1999 Dec)PubMedGoogle Scholar
  12. 12.
    Simoes, J.A., Giraldo, P.C., Ribbeiro Filho, A.D., et al.: Prevalencia e fatores de risco associados as infeccoes cervico-vaginais durante a gestacao. Rev. Bras. Ginecol. Obstet. 18(6), 459–467 (1996)Google Scholar
  13. 13.
    Franjola, R., Anazco, R., Puente, R., Moraleda, L., Herrmann, F., Palma, M.: Trichomonas vaginalis infection in pregnant women and newborn infants. Rev. Méd. Chile 117(2), 142–145 (1989 Feb)PubMedGoogle Scholar
  14. 14.
    Blankhart, D., Muller, O., Gresenguet, G., Weis, P.: Sexually transmitted infections in young pregnant women in Bangui, Central African Republic. Int. J. STD AIDS 10(9), 609–614 (1999 Sep)PubMedGoogle Scholar
  15. 15.
    Sturm, A.W., Wilkinson, D., Ndovela, N., Bowen, S., Connolly, C.: Pregnant women as a reservoir of undetected sexually transmitted diseases in rural South Africa: implications for disease control. Am. J. Publ. Health 88(8), 1243–1245 (1998 Aug)Google Scholar
  16. 16.
    Tyndall, M.W., Patrick, D., Spittal, P., Li, K., O’Shaughnessy, M.V., Schechter, M.T.: Risky sexual behaviours among injection drugs users with high HIV prevalence: implications for STD control. Sex. Transm. Infect. 78(suppl 1), i170–i175 (April 2002)PubMedGoogle Scholar
  17. 17.
    Morton, A.N., Wakefield, T., Tabrizi, S.N., Garland, S.M., Fairley, C.K.: An outreach programme for sexually transmitted infection screening in street sex workers using self-administered samples. Int. J. STD AIDS 10(11), 741–743 (Nov 1999)PubMedGoogle Scholar
  18. 18.
    Lee, D.M., Binger, A., Hocking, J., Fairley, C.K.: The incidence of sexually transmitted infections among frequently screened sex workers in a decriminalised and regulated system in Melbourne. Sex. Transm. Infect. 81(5), 434–436 (Oct 2005)PubMedGoogle Scholar
  19. 19.
    Shafer, M.A., Pantell, R.H., Schachter, J.: Is the routine pelvic examination needed with the advent of urine-based screening for sexually transmitted diseases? Arch. Pediatr. Adolesc. Med. 153(2), 119–125 (1999 Feb)PubMedGoogle Scholar
  20. 20.
    Kucinskiene, V., Sutaite, I., Valiukeviciene, S., Milasauskiene, Z., Domeika, M.: Prevalence and risk factors of genital Chlamydia trachomatis infection. Medicina (Kaunas) 42(11), 885–894 (2006)Google Scholar
  21. 21.
    Bunnell, R.E., Dahlberg, L., Rolfs, R., Ransom, R., Gershman, K., Farshy, C., et al.: High prevalence and incidence of sexually transmitted diseases in urban adolescent females despite moderate risk behaviors. J. Infect. Dis. 180(5), 1624–1631 (1999 Nov)PubMedGoogle Scholar
  22. 22.
    Burstein, G.R., Gaydos, C.A., Diener-West, M., Howell, M.R., Zenilman, J.M., Quinn, T.C.: Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA 280(6), 521–526 (1998 Aug 12)PubMedGoogle Scholar
  23. 23.
    Buve, A., Weiss, H.A., Laga, M., Van Dyck, E., Musonda, R., Zekeng, L., et al.: The epidemiology of gonorrhoea, chlamydial infection and syphilis in four African cities. AIDS 15(suppl 4), S79–S88 (2001 Aug)PubMedGoogle Scholar
  24. 24.
    Imai, H., Shinohara, H., Nakao, H., Tsukino, H., Hamasuna, R., Katoh, T.: Prevalence and risk factors of asymptomatic chlamydial infection among students in Japan. Int. J. STD AIDS 15(6), 408–414 (2004 Jun)PubMedGoogle Scholar
  25. 25.
    Ngandjio, A., Clerc, M., Fonkoua, M.C., Thonnon, J., Njock, F., Pouillot, R., et al.: Screening of volunteer students in Yaounde (Cameroon, Central Africa) for Chlamydia trachomatis infection and genotyping of isolated C. trachomatis strains. J. Clin. Microbiol. 41(9), 4404–4407 (Sept 2003)PubMedGoogle Scholar
  26. 26.
    Williams, H., Tabrizi, S.N., Lee, W., Kovacs, G.T., Garland, S.: Adolescence and other risk factors for Chlamydia trachomatis genitourinary infection in women in Melbourne, Australia. Sex. Transm. Infect. 79(1), 31–34 (2003 Feb)PubMedGoogle Scholar
  27. 27.
    Stamm, W.E.: Chlamydia trachomatis infections of the adult. In: Holmes, K.K., Sparling, P.F., Mardh, P., Lemon, S.M., Stamm, W.E., Plot, P., et al. (eds.) Sexually Transmitted Diseases, 3rd edn, pp. 407–422. McGraw-Hill, New York (1999)Google Scholar
  28. 28.
    Mardh, P.A.: Is Europe ready for STD screening? Genitourin. Med. 73(2), 96–98 (April 1997)PubMedGoogle Scholar
  29. 29.
    Wilson, J.S., Honey, E., Templeton, A., Paavonen, J., Mardh, P.A., Stray-Pedersen, B.: A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum. Reprod. Update 8(4), 385–394 (July–Aug 2002)PubMedGoogle Scholar
  30. 30.
    Sedlecki, K., Markovic, M., Rajic, G.: Risk factors for Chlamydia infections of the genital organs in adolescent females. Srp. Arh. Celok. Lek. 129(7–8), 169–174 (July–Aug 2001)PubMedGoogle Scholar
  31. 31.
    Cates Jr., W., Wasserheit, J.N.: Genital chlamydial infections: epidemiology and reproductive sequelae. Am. J. Obstet. Gynecol. 164(6 Pt 2), 1771–1781 (June 1991)PubMedGoogle Scholar
  32. 32.
    Burstein, G.R., Zenilman, J.M., Gaydos, C.A., Diener-West, M., Howell, M.R., Brathwaite, W., et al.: Predictors of repeat Chlamydia trachomatis infections diagnosed by DNA amplification testing among inner city females. Sex. Transm. Infect. 77(1), 26–32 (Feb 2001)PubMedGoogle Scholar
  33. 33.
    Hillis, S.D., Nakashima, A., Marchbanks, P.A., Addiss, D.G., Davis, J.P.: Risk factors for recurrent Chlamydia ­trachomatis infections in women. Am. J. Obstet. Gynecol. 170(3), 801–806 (Mar 1994)PubMedGoogle Scholar
  34. 34.
    Louv, W.C., Austin, H., Perlman, J., Alexander, W.J.: Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am. J. Obstet. Gynecol. 160(2), 396–402 (1989 Feb)PubMedGoogle Scholar
  35. 35.
    Kaptue, L., Zekeng, L., Djoumessi, S., Monny-Lobe, M., Nichols, D., Debuysscher, R.: HIV and chlamydia infections among prostitutes in Yaounde, Cameroon. Genitourin. Med. 67(2), 143–145 (1991 Apr)PubMedGoogle Scholar
  36. 36.
    Eron Jr., J.J., Gilliam, B., Fiscus, S., Dyer, J., Cohen, M.S.: HIV-1 shedding and chlamydial urethritis. JAMA 275(1), 36 (1996 Jan 3)PubMedGoogle Scholar
  37. 37.
    Fox, K.K., Whittington, W.L., Levine, W.C., Moran, J.S., Zaidi, A.A., Nakashima, A.K.: Gonorrhea in the United States, 1981-1996. Demographic and geographic trends. Sex. Transm. Dis. 25(7), 386–393 (Aug 1998)PubMedGoogle Scholar
  38. 38.
    Hook, E.W., HH, H.: Gonococcal infections in the adult. In: Holmes, K.K., Sparling, P.F., Mardh, P., Lemon, S.M., Stamm, W.E., Plot, P., et al. (eds.) Sexually Transmitted Diseases, 3rd edn, pp. 451–466. McGraw-Hill, New York (1999)Google Scholar
  39. 39.
    CDC: Sexually Transmitted Disease Surveillance, 2006 [cited; 192]. http://www.cdc.gov/std/stats/pdf/Surv2006.pdf(Nov 2007)
  40. 40.
    DeSchryver, A., Meheus, A.: Epidemiology of sexually transmitted diseases: the global picture. WHO Bull. OMS 68, 639–653 (1990)Google Scholar
  41. 41.
    Costello Daly, C., Wangel, A.M., Hoffman, I.F., Canner, J.K., Lule, G.S., Lema, V.M., et al.: Validation of the WHO diagnostic algorithm and development of an alternative scoring system for the management of women presenting with vaginal discharge in Malawi. Sex. Transm. Infect. 74(suppl 1), S50–S58 (June 1998)PubMedGoogle Scholar
  42. 42.
    WHO: STI/HIV status and trends of STI, HIV and AIDS at the end of the millennium [cited] http://www.who.int/hiv/strategic/en/wpr_millenium.pdf (1999)
  43. 43.
    Handsfield, H.H., Sparling, P.F.: Neisseria gonorrhoeae. In: Mandell, G.L., Bennett, J.E., Dolin, R. (eds.) Principles and Practice of Infectious Diseases, 6th edn, pp. 2514–2529. Churchill Livingstone, Philadelphia (2005)Google Scholar
  44. 44.
    WHO/EURO: Epidemic of sexually transmitted diseases in Eastern Europe. Report on a WHO meeting, Copenhagen, Denmark, 13–15 May 1996Google Scholar
  45. 45.
    Alary, M.: Epidemiology and control strategies. Can. J. Hum. Sexual 6, 13–17 (1997)Google Scholar
  46. 46.
    Miller, W.C., Ford, C.A., Morris, M., Handcock, M.S., Schmitz, J.L., Hobbs, M.M., et al.: Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 291(18), 2229–2236 (12 May 2004)PubMedGoogle Scholar
  47. 47.
    Fleming, D.T., Wasserheit, J.N.: From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex. Transm. Infect. 75(1), 3–17 (Feb 1999)PubMedGoogle Scholar
  48. 48.
    Ford, K., Norris, A.E.: Urban Hispanic adolescents and young adults: Relationship of acculturation to sexual behavior. J. Sex Res. 29, 189–205 (1993)Google Scholar
  49. 49.
    Weinstock, H., Berman, S., Cates Jr., W.: Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect. Sex. Reprod. Health 36(1), 6–10 (2004 Jan-Feb)PubMedGoogle Scholar
  50. 50.
    Datta, S.D., Sternberg, M., Johnson, R.E., Berman, S., Papp, J.R., McQuillan, G., et al.: Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann. Intern. Med. 147(2), 89–96 (2007 Jul 17)PubMedGoogle Scholar
  51. 51.
    Workowski, K.A., Berman, S.M.: Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm. Rep. 55(RR-11), 1–94 (2006 Aug 4)PubMedGoogle Scholar
  52. 52.
    Domantay-Apostol, G.P., Handog, E.B., Gabriel, M.T.: Syphilis: the international challenge of the great imitator. Dermatol. Clin. 26(2), 191–202, v (Apr 2008)Google Scholar
  53. 53.
    Walker, D.G., Walker, G.J.: Forgotten but not gone: the continuing scourge of congenital syphilis. Lancet Infect. Dis. 2(7), 432–436 (July 2002)PubMedGoogle Scholar
  54. 54.
    Golden, M.R., Marra, C.M., Holmes, K.K.: Update on syphilis: resurgence of an old problem. JAMA 290(11), 1510–1514 (17 Sept 2003)PubMedGoogle Scholar
  55. 55.
    Gottlieb, S.L., Pope, V., Sternberg, M.R., McQuillan, G.M., Beltrami, J.F., Berman, S.M., et al.: Prevalence of syphilis seroreactivity in the United States: data from the National Health and Nutrition Examination Surveys (NHANES) 2001-2004. Sex. Transm. Dis. 35(5), 507–511 (May 2008)PubMedGoogle Scholar
  56. 56.
    Ronald, A.R., Albritton, W.: Chancroid and Haemophilus ducreyi. In: Holmes, K.K., Sparling, P.F., Mardh, P., Lemon, S.M., Stamm, W.E., Plot, P., et al. (eds.) Sexually Transmitted Diseases, 3rd edn, pp. 515–523. McGraw-Hill, New York (1999)Google Scholar
  57. 57.
    Steen, R.: Eradicating chancroid. Bull. World Health Organ. 79(9), 818–826 (2001)PubMedGoogle Scholar
  58. 58.
    Al-Tawfiq, J.A., Spinola, S.M.: Haemophilus ducreyi: clinical disease and pathogenesis. Curr. Opin. Infect. Dis. 15(1), 43–47 (2002 Feb)PubMedGoogle Scholar
  59. 59.
    Mertz, K.J., Trees, D., Levine, W.C., Lewis, J.S., Litchfield, B., Pettus, K.S., et al.: Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. The Genital Ulcer Disease Surveillance Group. J. Infect. Dis. 178(6), 1795–1798 (1998 Dec)PubMedGoogle Scholar
  60. 60.
    Hanenberg, R.S., Rojanapithayakorn, W., Kunasol, P., Sokal, D.C.: Impact of Thailand’s HIV-control programme as indicated by the decline of sexually transmitted diseases. Lancet 344(8917), 243–245 (23 July 1994)PubMedGoogle Scholar
  61. 61.
    Weiss, H.A., Thomas, S.L., Munabi, S.K., Hayes, R.J.: Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis. Sex. Transm. Infect. 82(2), 101–109 (April 2006). discussion 10PubMedGoogle Scholar
  62. 62.
    O’Farrell, N.: Soap and water prophylaxis for limiting genital ulcer disease and HIV-1 infection in men in sub-Saharan Africa. Genitourin. Med. 69(4), 297–300 (1993 Aug)PubMedGoogle Scholar
  63. 63.
    O’Farrell, N.: Donovanosis. Sex. Transm. Infect. 78(6), 452–457 (Dec 2002)PubMedGoogle Scholar
  64. 64.
    O’Farrell, N.: Donovanosis. In: Holmes, K.K., Sparling, P.F., Mardh, P., Lemon, S.M., Stamm, W.E., Plot, P., et al. (eds.) Sexually Transmitted Diseases, 3rd edn, pp. 525–529. McGraw-Hill, New York (1999)Google Scholar
  65. 65.
    Bowden, F.J.: Donovanosis in Australia: going, going. Sex. Transm. Infect. 81(5), 365–366 (Oct 2005)PubMedGoogle Scholar
  66. 66.
    WHO: Consensus report on STI, HIV and AIDS Epidemiology Papua New Guinea [cited] http://www.wpro.who.int/NR/rdonlyres/EEC64817-5D9F-4E72-9F7C-6014887E3483/0/Consensus_Report_PNG_2000.pdf (2000)
  67. 67.
    Simmons, A.: Clinical manifestations and treatment considerations of herpes simplex virus infection. J. Infect. Dis. 186(suppl 1), S71–S77 (15 Oct 2002)PubMedGoogle Scholar
  68. 68.
    Freeman, E.E., Weiss, H.A., Glynn, J.R., Cross, P.L., Whitworth, J.A., Hayes, R.J.: Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20(1), 73–83 (2 Jan 2006)PubMedGoogle Scholar
  69. 69.
    Mertz, G.J., Benedetti, J., Ashley, R., Selke, S.A., Corey, L.: Risk factors for the sexual transmission of genital herpes. Ann. Intern. Med. 116(3), 197–202 (1 Feb 1992)PubMedGoogle Scholar
  70. 70.
    Fleming, D.T., McQuillan, G.M., Johnson, R.E., Nahmias, A.J., Aral, S.O., Lee, F.K., et al.: Herpes simplex virus type 2 in the United States, 1976 to 1994. N. Engl. J. Med. 337(16), 1105–1111 (16 Oct 1997)PubMedGoogle Scholar
  71. 71.
    Weiss, H.: Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 11(suppl 1), 24A–35A (Apr 2004)PubMedGoogle Scholar
  72. 72.
    Armstrong, G.L., Schillinger, J., Markowitz, L., Nahmias, A.J., Johnson, R.E., McQuillan, G.M., et al.: Incidence of herpes simplex virus type 2 infection in the United States. Am. J. Epidemiol. 153(9), 912–920 (1 May 2001)PubMedGoogle Scholar
  73. 73.
    Malkin, J.E.: Epidemiology of genital herpes simplex virus infection in developed countries. Herpes 11(suppl 1), 2A–23A (2004 Apr)PubMedGoogle Scholar
  74. 74.
    Fazel, N., Wilczynski, S., Lowe, L., Su, L.D.: Clinical, histopathologic, and molecular aspects of cutaneous human papillomavirus infections. Dermatol. Clin. 17(3), 521–536, viii (July 1999)Google Scholar
  75. 75.
    Ferlay, J., Bray, F., et al.: GLOBCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC Cancer Base, 2nd edn. IARC Press, Lyon (2004)Google Scholar
  76. 76.
    de Sanjose, S., Diaz, M., Castellsague, X., Clifford, G., Bruni, L., Munoz, N., et al.: Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect. Dis. 7(7), 453–459 (2007 Jul)PubMedGoogle Scholar
  77. 77.
    Munoz, N., Mendez, F., Posso, H., Molano, M., van den Brule, A.J., Ronderos, M., et al.: Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J. Infect. Dis. 190(12), 2077–2087 (15 Dec 2004)PubMedGoogle Scholar
  78. 78.
    Dunne, E.F., Unger, E.R., Sternberg, M., McQuillan, G., Swan, D.C., Patel, S.S., et al.: Prevalence of HPV infection among females in the United States. JAMA 297(8), 813–819 (28 Feb 2007)PubMedGoogle Scholar
  79. 79.
    Kahn, J.A., Lan, D., Kahn, R.S.: Sociodemographic factors associated with high-risk human papillomavirus infection. Obstet. Gynecol. 110(1), 87–95 (July 2007)PubMedGoogle Scholar
  80. 80.
    Baldwin, S.B., Wallace, D.R., Papenfuss, M.R., Abrahamsen, M., Vaught, L.C., Kornegay, J.R., et al.: Human papillomavirus infection in men attending a sexually transmitted disease clinic. J. Infect. Dis. 187(7), 1064–1070 (1 Apr 2003)PubMedGoogle Scholar
  81. 81.
    Castellsague, X., Bosch, F.X., Munoz, N., Meijer, C.J., Shah, K.V., de Sanjose, S., et al.: Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N. Engl. J. Med. 346(15), 1105–1112 (2002 Apr 11)PubMedGoogle Scholar
  82. 82.
    Clifford, G.M., Gallus, S., Herrero, R., Munoz, N., Snijders, P.J., Vaccarella, S., et al.: Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366(9490), 991–998 (17–23 Sept 2005)PubMedGoogle Scholar
  83. 83.
    Espinoza, L., Hall, H.I., Hardnett, F., Selik, R.M., Ling, Q., Lee, L.M.: Characteristics of persons with heterosexually acquired HIV infection, United States 1999-2004. Am. J. Publ. Health 97(1), 144–149 (Jan 2007)Google Scholar
  84. 84.
    WHO/EM: Report on the intercountry workshop on STD prevalence study, Amman, Jordan, 12–15 Oct 1998Google Scholar
  85. 85.
    McNaghten, A.D., Hanson, D.L., Aponte, Z., Sullivan, P.S., Wolfe, M.I.: Gender disparity in HIV treatment and AIDS opportunistic illnesses (OI). XV International conference on AIDS, Bangkok, Thailand, July 2004Google Scholar
  86. 86.
    McKenna, M.T., Hu, X.: Recent trends in the incidence and morbidity that are associated with perinatal human immunodeficiency virus infection in the United States. Am. J. Obstet. Gynecol. 197(suppl 3), S10–S16 (2007 Sep)PubMedGoogle Scholar
  87. 87.
    Over, M., Piot, P.: Human immunodeficiency virus infection and other sexually transmitted diseases in developing countries: public health importance and priorities for resource allocation. J. Infect. Dis. 174(suppl 2), S162–S175 (Oct 1996)Google Scholar
  88. 88.
    Bourgeois, A., Henzel, D., Dibanga, G., Malonga-Mouelet, G., Peeters, M., Coulaud, J.P., et al.: Prospective evaluation of a flow chart using a risk assessment for the diagnosis of STDs in primary healthcare centres in Libreville, Gabon. Sex. Transm. Infect. 74(suppl 1), S128–S132 (June 1998)PubMedGoogle Scholar
  89. 89.
    Jonsdottir, K., Geirsson, R.T., Steingrimsson, O., Olafsson, J.H., Stefansdottir, S.: Reduced prevalence of cervical Chlamydia infection among women requesting termination. Acta Obstet. Gynecol. Scand. 76(5), 438–441 (1997 May)PubMedGoogle Scholar
  90. 90.
    Hader, S.L., Smith, D.K., Moore, J.S., Holmberg, S.D.: HIV infection in women in the United States: status at the Millennium. JAMA 285(9), 1186–1192 (7 Mar 2001)PubMedGoogle Scholar
  91. 91.
    Prather, C., Fuller, T.R., King, W., Brown, M., Moering, M., Little, S., et al.: Diffusing an HIV prevention intervention for African American Women: integrating afrocentric components into the SISTA Diffusion Strategy. AIDS Educ. Prev. 18(4 suppl A), 149–160 (Aug 2006)PubMedGoogle Scholar
  92. 92.
    Leigh, B.C., Stall, R.: Substance use and risky sexual behavior for exposure to HIV. Issues in methodology, interpretation, and prevention. Am. Psychol. 48(10), 1035–1045 (Oct 1993)PubMedGoogle Scholar
  93. 93.
    McDavid, K., Li, J., Lee, L.M.: Racial and ethnic disparities in HIV diagnoses for women in the United States. J. Acq. Immun. Def. Synd. 42(1), 101–107 (May 2006)Google Scholar
  94. 94.
    Truong, H.M., Kellogg, T., Klausner, J.D., Katz, M.H., Dilley, J., Knapper, K., et al.: Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting? Sex. Transm. Infect. 82(6), 461–466 (December 2006)PubMedGoogle Scholar
  95. 95.
    Millett, G., Malebranche, D., Mason, B., Spikes, P.: Focusing “down low”: bisexual black men, HIV risk and heterosexual transmission. J. Natl. Med. Assoc. 97(7 suppl), 52S–59S (July 2005)PubMedGoogle Scholar
  96. 96.
    Fullilove, R.E.: African Americans, Health Disparities and HIV/AIDS: Recommendations for Confronting the Epidemic in Black America. Columbia University, National Minority AIDS Council, New York (2006)Google Scholar
  97. 97.
    DeNavas-Walt, C., Proctor, B.D., Lee, C.H.: Income, poverty, and health insurance coverage in the United States: 2004. Current Population Reports, pp. 60–229. U.S. Government Printing Office, Washington (2005)Google Scholar
  98. 98.
    Valleroy, L.A., MacKellar, D.A., Behel, S.K., Secura, G.M.: Young men’s survey. The bridge for HIV transmission to women from 23- to 29-year-old men who have sex with men in 6 U.S. cities. National HIV prevention conference, Atlanta, Georgia, JulyGoogle Scholar
  99. 99.
    MacKellar, D.A., Valleroy, L.A., Secura, G.M., Behel, S., Bingham, T., Celentano, D.D., et al.: Unrecognized HIV infection, risk behaviors, and perceptions of risk among young men who have sex with men: opportunities for advancing HIV prevention in the third decade of HIV/AIDS. J. Acq. Immun. Def. Synd. 38(5), 603–614 (15 Apr 2005)Google Scholar
  100. 100.
    Connor, E.M., Sperling, R.S., Gelber, R., Kiselev, P., Scott, G., O’Sullivan, M.J., et al.: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N. Engl. J. Med. 331(18), 1173–1180 (3 Nov 1994)PubMedGoogle Scholar
  101. 101.
    Cooper, E.R., Charurat, M., Mofenson, L., Hanson, I.C., Pitt, J., Diaz, C., et al.: Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acq Immun Def Synd 29(5), 484–494 (15 Apr 2002)Google Scholar
  102. 102.
  103. 103.
    Parkin, D.M., Bray, F., Ferlay, J., Pisani, P.: Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 94(2), 153–156 (15 Oct 2001)PubMedGoogle Scholar
  104. 104.
    McGlynn, K.A., Tsao, L., Hsing, A.W., Devesa, S.S., Fraumeni Jr., J.F.: International trends and patterns of primary liver cancer. Int. J. Cancer 94(2), 290–296 (15 Oct 2001)PubMedGoogle Scholar
  105. 105.
    WHO: Hepatitis B: Fact sheet no. 204 (revised Oct 2000) [cited] http://www.who.int/mediacentre/factsheets/fs204/en/index.html (2000)
  106. 106.
    Hepatitis B vaccines: Releve epidemiologique hebdomadaire/Section d’hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record/Health Section of the Secretariat of the League of Nations, 9;79(28):255–263 (July 2004)Google Scholar
  107. 107.
    Lavanchy, D.: Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J. Clin. Virol. 34(suppl 1), S1–S3 (2005 Dec)PubMedGoogle Scholar
  108. 108.
    Introduction of Hepatitis B vaccine into childhood immunization services: Management guidelines including information for health workers and parents [cited] http://www.who.int/vaccines-documents/DocsPDF01/www613.pdf (2001)
  109. 109.
    Disease burden from Hepatitis A, B, and C in the United States [cited] www.cdc.gov/ncidod/diseases/hepatitis/resource/PDFs/disease_burden.pdf
  110. 110.
    Wasley, A., Grytdal, S., Gallagher, K.: Surveillance for acute viral hepatitis–United States, 2006. MMWR Surveill. Summ. 57(2), 1–24 (21 Mar 2008)PubMedGoogle Scholar
  111. 111.
    Smith, K.J., Yeager, J., Skelton, H.: Molluscum contagiosum: its clinical, histopathologic, and immunohistochemical spectrum. Int. J. Dermatol. 38(9), 664–672 (1999 Sep)PubMedGoogle Scholar
  112. 112.
    Porter, C.D., Archard, L.C.: Characterisation by restriction mapping of three subtypes of molluscum contagiosum virus. J. Med. Virol. 38(1), 1–6 (Sept 1992)PubMedGoogle Scholar
  113. 113.
    Shirodaria, P.V., Matthews, R.S.: Observations on the antibody rsponses in molluscum contagiosum. Br. J. Dermatol. 96(1), 29–34 (Jan 1977)PubMedGoogle Scholar
  114. 114.
    Becker, T.M., Blount, J.H., Douglas, J., Judson, F.N.: Trends in molluscum contagiosum in the United States, 1966-1983. Sex. Transm. Dis. 13(2), 88–92 (Apr–June 1986)PubMedGoogle Scholar
  115. 115.
    Lowy, D.R., Androphy, E.J.: Molluscum contagiosum. In: Freedberg, I.M., Eisen, A.Z., Wolff, K., Austen, K.F., Goldsmith, L.A., Katz, S.I. (eds.) Fitzpatrick’s Dermatology in General Medicine, 6th edn. McGraw-Hill, New York (2003)Google Scholar
  116. 116.
    Strauss, R.M., Doyle, E.L., Mohsen, A.H., Green, S.T.: Successful treatment of molluscum contagiosum with topical imiquimod in a severely immunocompromised HIV-positive patient. Int. J. STD AIDS 12(4), 264–266 (Apr 2001)PubMedGoogle Scholar
  117. 117.
    Schwartz, J.J., Myskowski, P.L.: Molluscum contagiosum in patients with human immunodeficiency virus infection. A review of twenty-seven patients. J. Am. Acad. Dermatol. 27(4), 583–588 (Oct 1992)PubMedGoogle Scholar
  118. 118.
    Romiti, R., Ribeiro, A.P., Romiti, N.: Evaluation of the effectiveness of 5% potassium hydroxide for the treatment of molluscum contagiosum. Pediatr. Dermatol. 17(6), 495 (Nov–Dec 2000)PubMedGoogle Scholar
  119. 119.
    Lee, B., Kang, H.Y.: Molluscum folliculitis after leg shaving. J. Am. Acad. Dermatol. 51(3), 478–479 (Sept 2004)PubMedGoogle Scholar
  120. 120.
    National Guideline for the Management of Molluscum Contagiosum: Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). Sex Transm. Infect. 75(suppl 1):S80–S81 (Aug 1999)Google Scholar
  121. 121.
    Buckley, R., Smith, K.: Topical imiquimod therapy for chronic giant molluscum contagiosum in a patient with advanced human immunodeficiency virus 1 disease. Arch. Dermatol. 135(10), 1167–1169 (1999 Oct)PubMedGoogle Scholar
  122. 122.
    Petersen, C.S., Gerstoft, J.: Molluscum contagiosum in HIV-infected patients. Dermatology 184(1), 19–21 (1992)PubMedGoogle Scholar
  123. 123.
    Picon, L., Vaillant, L., Duong, T., Lorette, G., Bacq, Y., Besnier, J.M., et al.: Cutaneous cryptococcosis resembling molluscum contagiosum: a first manifestation of AIDS. Acta Derm. Venereol. 69(4), 365–367 (1989)PubMedGoogle Scholar
  124. 124.
    Cobbold, R.J., Macdonald, A.: Molluscum contagiosum as a sexually transmitted disease. Practitioner 204(221), 416–419 (Mar 1970)PubMedGoogle Scholar
  125. 125.
    Billstein, S.A., Mattaliano Jr., V.J.: The “nuisance” sexually transmitted diseases: molluscum contagiosum, scabies, and crab lice. Med. Clin. N. Am. 74(6), 1487–1505 (Nov 1990)PubMedGoogle Scholar
  126. 126.
    Leone, P.A.: Scabies and pediculosis pubis: an update of treatment regimens and general review. Clin. Infect. Dis. 44(suppl 3), S153–S159 (1 Apr 2007)PubMedGoogle Scholar
  127. 127.
    Haag, M.L., Brozena, S.J., Fenske, N.A.: Attack of the scabies: what to do when an outbreak occurs. Geriatrics 48(10), 45–46, 51–53 (Oct 1993)Google Scholar
  128. 128.
    Kolar, K.A., Rapini, R.P.: Crusted (Norwegian) scabies. Am. Fam. Physician 44(4), 1317–1321 (1991 Oct)PubMedGoogle Scholar
  129. 129.
    Mathieu, M.E., Wilson, B.B.: Scabies. In: Mandell, G.L., Bennett, J.E., Dolin, R. (eds.) Principles and Practice of Infectious Diseases, 6th edn, pp. 3304–3307. Churchill Livingstone, London (2005)Google Scholar
  130. 130.
    Chosidow, O.: Clinical practices. Scabies. N. Engl J. Med. 354(16), 1718–1727 (20 Apr 2006)PubMedGoogle Scholar
  131. 131.
    Mandell, G.L., Bennett, J.E., Dolin, R. (eds.): Principles and Practice of Infectious Diseases, 5th ed., pp. 2972–2973. Churchill Livingstone, London (2000)Google Scholar
  132. 132.
    Varela, J.A., Otero, L., Espinosa, E., Sanchez, C., Junquera, M.L., Vazquez, F.: Phthirus pubis in a sexually transmitted diseases unit: a study of 14 years. Sex. Transm. Dis. 30(4), 292–296 (Apr 2003)PubMedGoogle Scholar
  133. 133.
    Manjunatha, N.P., Jayamanne, G.R., Desai, S.P., Moss, T.R., Lalik, J., Woodland, A.: Pediculosis pubis: presentation to ophthalmologist as pthriasis palpebrarum associated with corneal epithelial keratitis. Int. J. STD AIDS 17(6), 424–426 (June 2006)PubMedGoogle Scholar
  134. 134.
    Orion, E., Matz, H., Wolf, R.: Ectoparasitic sexually transmitted diseases: scabies and pediculosis. Clin. Dermatol. 22(6), 513–519 (Nov–Dec 2004)PubMedGoogle Scholar
  135. 135.
    Stone, S.P.: Scabies and pediculosis. In: Freedberg, I.M., Eisen, A.Z., Wolff, K., Austen, K.F., Goldsmith, L.A., Katz, S.I. (eds.) Fitzpatrick’s Dermatology in General Medicine, 6th edn, pp. 2283–2289. McGraw-Hill, New York (2003)Google Scholar
  136. 136.
    Kralj, B., Kansky, A., Zgavec, B., Kraigher, A.: Scabies in Slovenia during the 1971-95 period. Acta Dermatoven APA 6, 33–36 (1997)Google Scholar
  137. 137.
    Stork, J.: Scabies. Cesko-slovenska Dermatol. 74, 28–33 (1999)Google Scholar
  138. 138.
    Kansky, A., Potocnik, M., Kraigher, A.: Scabies and venereal diseases in Slovenia. Acta Dermatoven APA 6(suppl), 1–16 (1997)Google Scholar
  139. 139.
    Wendel, K., Rompalo, A.: Scabies and pediculosis pubis: an update of treatment regimens and general review. Clin. Infect. Dis. 35(suppl 2), S146–S151 (15 Oct 2002)PubMedGoogle Scholar
  140. 140.
    Konstantinov, D., Stanoeva, L., Zaharijeva, L., Bitoljanu, V.: Epidemiological factors causing the present outbreak of scabies epidemic in the Socialist Republic of Macedonia. Acta Derm. Lug. 4, 225–233 (1977)Google Scholar
  141. 141.
    Mimouni, D., Grotto, I., Haviv, J., Gdalevich, M., Huerta, M., Shpilberg, O.: Secular trends in the epidemiology of pediculosis capitis and pubis among Israeli soldiers: a 27-year follow-up. Int. J. Dermatol. 40(10), 637–639 (Oct 2001)PubMedGoogle Scholar
  142. 142.
    Meinking, T.L., Burkhart, C.G., Burkhart, C.N.: Infestations. In: Bolognia, J.L., Jorizzo, J.L., Rapini, R.P. (eds.) Dermatology, pp. 1321–1332. Mosby, London (2003)Google Scholar
  143. 143.
    CDC: Ectoparasitic infections. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm. Rep. 55(RR-11), 79–80 (10 Aug 2002)Google Scholar
  144. 144.
    Armstrong, N.R., Wilson, J.D.: Did the “Brazilian” kill the pubic louse? Sex. Transm. Infect. 82(3), 265–266 (2006 Jun)PubMedGoogle Scholar
  145. 145.
    CDC: Parasitic disease information: scabies fact sheet [cited] http://www.cdc.gov/ncidod/dpd/parasites/scabies/factsht_scabies.htm (2005)

Copyright information

© Springer Berlin Heidelberg 2011

Authors and Affiliations

  • Aron Gewirtzman
    • 1
  • Laura Bobrick
    • 1
  • Kelly Conner
    • 2
  • Stephen K. Tyring
    • 3
  1. 1.Center for Clinical StudiesHoustonUSA
  2. 2.University of Texas Health Science CenterHoustonUSA
  3. 3.Department of DermatologyUniversity of Texas Health Science CenterHoustonUSA

Personalised recommendations